Nexara Health — Health Canada Drug Establishment Licence #3-002896

ACTIVELLE LD 0.5 MG

Last verified 2026-09-08 · Source: Health Canada Drug Product Database (DPD), DIN 02309009

ACTIVELLE LD 0.5 MG

ESTRADIOL : 0.5 MG NORETHINDRONE ACETATE : 0.1 MG · DIN 02309009 · NOVO NORDISK CANADA INC

Health Canada status: MARKETED

What is ACTIVELLE LD?

ACTIVELLE LD 0.5 MG contains ESTRADIOL : 0.5 MG NORETHINDRONE ACETATE : 0.1 MG. It is listed in the Health Canada Drug Product Database under DIN 02309009, held by NOVO NORDISK CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-May-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ACTIVELLE LD used for?

Treatment of moderate to severe vasomotor symptoms occurring in naturally or surgically induced estrogen deficiency states associated with menopause in women with intact uteri.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02309009
Brand nameACTIVELLE LD
Generic / active ingredientESTRADIOL : 0.5 MG NORETHINDRONE ACETATE : 0.1 MG
ManufacturerNOVO NORDISK CANADA INC
Strength0.5 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeG03FA01 NORETHISTERONE AND ESTROGEN
AHFS class68:32.00 ; 68:16.04
BiosimilarNo
Health Canada statusMARKETED
Status date16-May-2008
Original market date2008-05-16 00:00:00

How is it administered?

One tablet taken orally once a day without interruption, preferably at the same time every day. Re-evaluate within 3-6 months.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Not explicitly detailed in provided text (section 11 not included in snippet).

How is it supplied?

Calendar dial packs of 1x28 tablets or 3x28 tablets.

Contraindications

Hypersensitivity; liver disease; estrogen/progestin-dependent neoplasia; endometrial hyperplasia; breast cancer; undiagnosed genital bleeding; pregnancy; arterial/venous thromboembolism; porphyria.

Warnings and precautions

Increased risk of MI, stroke, invasive breast cancer, pulmonary emboli, DVT, and dementia. Use lowest effective dose for shortest duration. Monitor blood pressure and breast health.

What can be used instead?

Other Canadian products sharing ATC code G03FA01 NORETHISTERONE AND ESTROGEN. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACTIVELLE1 MGTABLETNOVO NORDISK CANADA INCMARKETEDDIN 02249405
ESTALIS 140/50 MCG140 MCG / 50MCGPATCHSANDOZ CANADA INCORPORATEDMARKETEDDIN 02241835
ESTALIS 250/50 MCG250 MCG / 24 HOURPATCHSANDOZ CANADA INCORPORATEDMARKETEDDIN 02241837
FEMHRT5 MCGTABLETWARNER CHILCOTT CANADA COCANCELLED POST MARKETDIN 02242531

Who else supplies NORETHISTERONE AND ESTROGEN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. NORETHISTERONE AND ESTROGEN appears in 14 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ACTIVELLE LD

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Related pages

Sourcing this product